Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ATHN > SEC Filings for ATHN > Form 8-K on 24-Oct-2013All Recent SEC Filings

Show all filings for ATHENAHEALTH INC



Change in Directors or Principal Officers, Financial Statements and Exhibits

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Appointment of Amy Abernethy
On October 22, 2013, the Board of Directors (the "Board") of athenahealth, Inc. ("athenahealth") appointed Amy Abernethy, MD, Ph.D. to the Board. Dr. Abernethy was appointed to fill an existing vacancy on Class I of the Board and will hold office until the annual meeting of athenahealth stockholders in 2014 or until her earlier resignation, death, or removal. Dr. Abernethy will serve on the audit committee of the Board.
Dr. Abernethy will receive athenahealth's standard non-employee director cash and equity compensation. She will receive a $20,000 annual retainer paid in quarterly installments, $3,000 for each board or committee meeting attended in-person, $1,000 for each board or committee call or in-person meeting attended by phone, and an annual equity award having a value of $175,000 in the form or stock options or restricted stock units (or any combination of stock options and restricted stock units) at a 2:1 stock-option-to-restricted-stock-unit ratio at her election. In connection with her appointment, Dr. Abernethy will receive a pro-rated equity award of 1,246 restricted stock units, which will fully vest on June 1, 2014.
Dr. Abernethy will enter into athenahealth's standard form of indemnification agreement.
A copy of the press release announcing the appointment of Dr. Abernethy is attached hereto as Exhibit 99.1.
2013 CEO Equity Award Modification
On October 22, 2013, the compensation committee (the "Committee") of the Board approved an amendment of the stock option granted to Jonathan Bush, the President, Chief Executive Officer, and Chairman of the Board, on March 1, 2013, to purchase 182,000 shares of athenahealth common stock (the "2013 Stock Option"). The 2013 Stock Option was amended to provide that 50% of the shares subject to the award (the "Performance-based Portion") will become vested and exercisable only if, following the fiscal year 2014, the Committee certifies that the following performance criteria have been met for athenahealth's fiscal year 2014: (1) annual revenue growth over fiscal year 2013 of 20% or greater; and (2) Non-GAAP Adjusted Gross Margin of 50% or greater.* If both performance criteria are met, then the Performance-based Portion of the 2013 Stock Option shall vest as follows:
45,500 shares (50%) 3/1/2015
22,750 shares (25%) 3/1/2016
22,750 shares (25%) 3/1/2017

If, following fiscal year 2014, the Committee determines that the performance criteria have not been met, then the Performance-based Portion of the 2013 Stock Option shall immediately and automatically be forfeited. The 50% of the shares subject to the 2013 Stock Option that are not subject to the performance criteria will continue to vest and be exercisable in accordance with the original vesting schedule as follows:
22,750 shares (25%) 3/1/2014
22,750 shares (25%) 3/1/2015
22,750 shares (25%) 3/1/2016
22,750 shares (25%) 3/1/2017

* "Non-GAAP Adjusted Gross Margin" means Non-GAAP Adjusted Gross Profit as a percentage of total revenue and "Non-GAAP Adjusted Gross Profit" means total revenue less direct operating expense plus (1) stock-based compensation expense allocated to direct operating expense and (2) amortization of purchased intangible assets allocated to direct operating expense.

Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.                                Description
99.1           Press release issued by athenahealth, Inc. on October 24, 2013,
               furnished herewith.

  Add ATHN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ATHN - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.